Rhythm Biosciences Ltd has released a press release.
Rhythm Completes Reagent Development Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Appointment of CEO - Senior Management Changes
- AGM Presentation
- Final Antibody Selection Complete
- Rhythm completes cloning of key reagent ahead of schedule
- Rhythm Granted Biomarker Patent in Europe
Later from Rhythm Biosciences
- Corporate Presentation
- RHY Signs first ColoSTAT site for Clinical Trial - Study 7
- Rhythm recruits first patient in ColoSTAT clinical trial
- Rhythm Biosciences receives ISO certification
- Monash Health signed with first patients recruited
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences